Annotated digest of in-vitro and animal-model literature on BPC-157 (the 15-amino-acid gastric-juice-derived fragment) and TB-500 (Ac-LKKTETQ, the actin-binding fragment of thymosin beta-4). Sequence-verification methods, cellular-mechanism studies, and stability characterization findings reported in peer-reviewed sources.
BPC-157 is a synthetic 15-amino-acid peptide (GEPPPGKPADDAGLV) corresponding to a fragment originally isolated from human gastric juice. Published preclinical investigations characterize its proposed cytoprotective and angiogenic signalling, including animal-model studies of tendon fibroblast biology, neuromuscular-junction stability, and gastrointestinal-tract observations under stress models.
TB-500 refers to the N-terminally acetylated heptapeptide Ac-LKKTETQ, corresponding to residues 17–23 of thymosin beta-4. The fragment encompasses the actin-binding motif of the parent protein and has been the subject of doping-control method development as well as basic-science work on cell migration, angiogenesis, and cytoskeletal organization.
Disclaimer · Citations are provided as reference material from the published research literature. Strata sells research compounds for laboratory use only and does not interpret, recommend, or extrapolate findings to human application.